# Olga M. Lapeyra, M.D. – FDA Inspection, Jun 7, 2024

Source: https://www.keypedia.com/records/fda_inspections/olga-m-lapeyra-md/f829afae-288a-47e6-a8e9-e1600c32419d
Source feed: FDA_Inspections

> FDA inspection 1240835 of Olga M. Lapeyra, M.D., June 07, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1240835
- Company Name: Olga M. Lapeyra, M.D.
- Inspection Date: 2024-06-07
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1155019 - 2021-10-25](https://www.keypedia.com/records/fda_inspections/olga-m-lapeyra-md/e78f0715-db1e-4793-9da1-87610956fbeb)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/chantae-d-mitchell/0da68244-86f3-4119-b965-0b2dceb1c523)

Company: https://www.keypedia.com/companies/olga-m-lapeyra-md/61d3f920-9aca-42fa-a383-758a3d1f6b59

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
